DexCom (DXCM) - Shares outstanding

Number of shares outstanding as of November 2026 : 374,700,000

According to DexCom's latest financial reports and stock price the company's current number of shares outstanding is 374,700,000. At the end of 2024 the company had 390,200,000 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.

Shares outstanding history for DexCom from 2022 to 2024

Shares Outstanding at the end of each year

Year	Shares Outstanding	Change
2024	0.39 B	1.59%
2023	0.38 B	-0.57%
2022	0.38 B

Shares Outstanding for similar companies or competitors

Company	Shares Outstanding	differencediff.	Country
Johnson & Johnson JNJ	2,409,600,000	543.07%	🇺🇸 USA
Abbott Laboratories ABT	1,730,383,296	361.80%	🇺🇸 USA
Medtronic MDT	1,279,800,000	241.55%	🇮🇪 Ireland
Becton Dickinson BDX	274,788,000	-26.66%	🇺🇸 USA
Edwards Lifesciences EW	576,400,000	53.83%	🇺🇸 USA
Tandem Diabetes Care TNDM	69,011,000	-81.58%	🇺🇸 USA
QuidelOrtho QDEL	68,300,000	-81.77%	🇺🇸 USA
West Pharmaceutical Services WST	70,400,000	-81.21%	🇺🇸 USA

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

Number of shares outstanding for DexCom (DXCM)

Number of shares outstanding as of November 2026 : 374,700,000